In Vitro Antioxidant, Anti-Inflammatory, and Digestive Enzymes Inhibition Activities of Hydro-Ethanolic Leaf and Bark Extracts of Psychotria densinervia (K. Krause) Verdc

Psychotria densinervia hydro-ethanolic leaf extract (PHELE) and bark extract (PHEBE) were evaluated for antioxidant, anti-inflammatory, and inhibition of digestive enzymes activities. The antioxidant activity was characterized by 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS), ferric reducing antioxidant power (FRAP), total phenolic content (TPC), and total flavonoid content (TFC) assays. The anti-inflammatory activity was characterized by protein denaturation and antiproteinase tests, while the inhibition of the enzymes was assessed using α-amylase, α-glucosidase, lipase, and cholesterol esterase activities. PHELE presented low (p < 0.001) IC50 (59.09 ± 5.97 μg/ml) for DPPH compared with ascorbic acid (71.78 ± 6.37 μg/ml) and PHEBE (115.40 ± 1.21 μg/ml). The IC50 of PHELE (262.4 ± 4.46 μg/ml) and PHEBE (354.2 ± 1.97 μg/ml) was higher (p < 0.001) than that of catechin (33.48 ± 2.02 μg/ml) for ABTS. PHELE had high (p < 0.001) FRAP (341.73 ± 21.70 mg CE/g) than PHEBE (150.30 ± 0.32 mg CE/g). PHELE presented (p < 0.001) high TPC (270.05 ± 7.53 mg CE/g) and TFC (23.43 ± 0.032 mg CE/g) than PHEBE (TPC: 138.89 ± 0.91 and TFC: 20.06 ± 0.032 mg CE/g). PHELE showed antiprotein denaturation with IC50 (257.0 ± 7.51 μg/ml) (p < 0.001) and antiproteinase activity (74.37 ± 1.10 μg/ml) lower than PHEBE (316.1 ± 6.02 μg/ml and 177.6 ± 0.50 μg/ml), respectively. Orlistat inhibited lipase (p < 0.001) activity with IC50 (37.11 ± 4.39 μg/ml) lower than PHELE and PHEBE (50.57 ± 2.89 μg/ml and 62.88 ± 1.74 μg/ml, respectively). PHELE inhibited cholesterol esterase with IC50 (34.75 ± 3.87 μg/ml) lower than orlistat (54.61 ± 2.56) and PHEBE (80.14 ± 1.71 μg/ml). PHELE inhibited α-amylase IC50 (6.07 ± 4.05 μg/ml) lower than PHEBE (19.69 ± 6.27 μg/ml) and acarbose (20.01 ± 2.84 μg/ml). Acarbose inhibited α-glucosidase (p < 0.001) activity with IC50 (4.11 ± 3.47 μg/ml) lower than PHELE (24.41 ± 2.84 μg/ml) and PHEBE (38.81 ± 2.46 μg/ml). PHELE presented better antioxidant, anti-inflammatory, and enzyme inhibition activity than PHEBE.


Introduction
Overweight and obesity are defined as abnormal or excessive fat accumulation, which presents a risk to health [1]. In 2016, more than 1.9 billion adults, 18 years and older, were overweight. Of these, over 650 million were obese [2]. Obesity is now at epidemic proportions globally, with more than 2.8 million people dying each year [3]. Obesity has been associated with the pathogenesis of chronic diseases, such as cardiac injury, hypertension, and type 2 diabetes [4]. Obesity and overweight are a consequence of lipid accumulation in the form of triglycerides in the adipose tissue [5]. e main source of adipocyte triglycerides is chylomicrons and very low-density lipoproteins (VLDL), which are often obtained from food or liver lipogenesis [5]. In the digestive system, the dietary lipids undergo hydrolysis catalyzed by pancreatic lipases, cholesterol esterase, and phospholipases to yield free fatty acids, free cholesterol, and lysophosphatidic acid, respectively. Carbohydrates will undergo hydrolysis catalyzed by salivary and pancreatic α-amylase as well as α-glucosidases to yield simple sugars. One of the approaches in the fight against obesity and related diseases such as type II diabetes would be to search for new molecules that are able to inhibit the activity of the digestive enzymes earlier mentioned. Secondary metabolites of certain plant extracts have shown their effectiveness in the fight against obesity by regulating oxidative stress and inflammation and by inhibiting the digestive enzymes responsible for the hydrolysis of lipids and carbohydrates [6].
e Psychotria genus belongs to the family of Rubiaceae commonly used in traditional medicine for the treatment of several disease conditions. Phytochemical studies on the Psychotria genus revealed the presence of secondary metabolites such as alkaloids (indoles, monoterpene indoles, quinolines, and isoquinolines), flavonoids, terpenoids, and coumarins [7]. Amongst this genus, Psychotria densinervia is the most abundant and commonly found plant in the dense forest of Cameroon [8]. Psychotria densinervia is a large shrub measuring 3 m in height with a pale whitish-grey stem. Its petioles are pale green above and brown below. e leaves are smooth, leathery, and dark green. e flowers are yellow and the fruits are dull dark red to pale green. is plant is used by the local population in the treatment of malaria [8] and other complications related to cardiovascular diseases. It also has diuretic properties and facilitates digestion due to which it is referred to as a slimming plant in the locality of the Southern Region of Cameroon. However, studies related to the weight loss activity remain limited.
is study evaluated the antioxidant, anti-inflammatory, and digestive enzymes' inhibitory properties of hydroethanolic extracts of Psychotria densinervia leaves and bark.

Preparation of the Hydro-Ethanolic Leaf and Bark Extracts of Psychotria densinervia.
e fresh leaves and bark of P. densinervia ( Figure 1) were harvested in the Southern Region of Cameroon; the identification was done by Dr. Tsabang Nole at the National Herbarium of Yaoundé-Cameroon with the identification number No. 58226 HNC. Plant parts (leaves and bark) were washed with distilled water three times and shade-dried for two weeks at room temperature. Each dried material (546.2 g and 426.6 g for leaf and bark, respectively) was ground and macerated separately with a hydro-ethanolic solution (70% ethanol and 30% distilled water, v : v) at 35°C for three days. e extracts were then filtered and evaporated with the aid of a rotavapor, dried in an oven at 50°C, and labeled as PHELE (leaf extract) and PHEBE (bark extract). e PHELE and PHEBE were stored at −4°C for subsequent use.

Preliminary Phytochemical Screening.
e presence of possible phytochemical components in the extracts was determined by color change due to the reaction between the principal reagents and specific bioactive components (phenolic compounds, flavonoids, alkaloids, tannins, coumarins, steroids, saponins, and terpenoids). e color intensity is determined by the abundance of a particular compound.

Test for Phenolic Compounds.
A few drops of 5% glacial acetic acid were added to 1 ml of each leaf and bark extract, followed by the addition of a few drops of 5% NaNO 2 solution. e muddy brown color developed revealed the presence of phenols in the test samples [9].

Test for Flavonoids.
e extract (1 ml) was taken into a test tube and a few drops of diluted NaOH solution were added. An intense yellow color, which fades to colorless on the addition of a few drops of diluted acid, indicated the presence of flavonoids [10].

Test for Alkaloids.
Mayer's test was used for the determination of alkaloids [9]. According to this test procedure, 2 ml of concentrated HCl was added to 2 ml of the respective leaf and bark extract followed by the addition of a few drops of Mayer's reagent. e development of a  e DPPH scavenging assay was conducted by the method of Sanchez-Moreno et al. [11] with some modifications. DPPH_ (0.1 mM) stock solution was diluted in methanol, and the absorbance was adjusted to 1.5 at 517 nm wavelength. P. densinervia extracts (500 μl) at different concentrations (15.62, 31.25, 62.5, and 250 μg/ml) were mixed with 2000 μl of DPPH solution and read with the aid of a spectrophotometer at 517 nm after 30 mins of incubation in the dark. Ascorbic acid was used as a standard, and the percentage of inhibition was calculated using the following formula: where test � absorbance of the sample (plant extract or ascorbic acid) and blank � absorbance of DPPH alone. e 50% inhibition concentration (IC 50 ) was calculated from the regression equation.

ABTS (2,2′-Azinobis(3-ethylbenzothiazoline 6-Sulfonic
Acid)) Radical Scavenging Method. ABTS scavenging activity was evaluated by the discoloration of the cationic radical ABTS * + , as per the technique described by Arnao et al. [12] with some modifications. Briefly, the ABTS reagent was obtained by mixing an ethanolic solution of ABTS (7.4 mM) and an aqueous solution of potassium persulfate (2.6 mM). After mixing, the solution was incubated in the dark for 24 hours. e ABTS solution obtained was diluted until an absorbance of 1.5 was obtained at 734 nm. Two hundred microliters of each extract or catechin at different concentrations (15.62, 31.25, 62.5, and 250 μg/ml) was added to 1800 μl of the ABTS solution prepared above. e mixture was incubated in the dark for 15 mins, and the absorbance was read with a spectrophotometer at 734 nm against the blank. Catechin was used as the standard. e percentage of inhibition was calculated using the following formula: where test � absorbance of sample (plant extract or catechin) and blank � absorbance of ABTS alone. e IC 50 was calculated as in DPPH.
en, 75 μL of each extract (1000 μg/ml) was added to 2000 μl of the FRAP reagent. e mixture was incubated at 37°C for 30 mins, and the absorbance was read at 595 nm against the blank. A calibration curve was plotted from the results of a diluted series of catechin (7.81, 15.62, 31.25, 62.50, 125, and 250 μg/ ml) treated in the same manner as the extracts. e results were expressed as milligrams of catechin equivalent per gram of extract (mg CE/g of extract).

Total Phenolic Content (TPC) Assay.
e total phenolic content was determined according to the Folin-Ciocalteu (FC) method [14] with slight modifications. Briefly, 200 μl of extract or standard (1000 μg/ml) was mixed with 1000 μl of Folin-Ciocalteu reagent diluted 10 times and the mixture was incubated for 4 mins. en, 800 μl of sodium carbonate solution (75000 μg/ml) was added, and the mixture was incubated for 2 hours at room temperature. en, the absorbance was read in a spectrophotometer at 765 nm against a blank. A calibration curve was plotted from the results of a dilution series of catechin (7.81, 15.62, 31.25, 62.5, 125, and 250 μg/ml). e results were expressed as milligrams of catechin equivalent per gram of extract (mg CE/g of extract).

Flavonoid Content Assay.
e flavonoid content was determined following the method described by Jia et al. [15] with some modifications. Briefly, 500 μl of extract (500 μg/ ml) was mixed with 150 μl of 5% sodium nitrate and incubated for 5 mins at room temperature. en, 150 μl of 10% aluminum trichloride and 1 ml of 1 M sodium hydroxide Advances in Pharmacological and Pharmaceutical Sciences were added to the mixture and the volume was made up to 5000 μl with distilled water. e mixture was incubated for 10 mins, and the absorbance was read in a spectrophotometer at 510 nm against a blank. A standard curve was plotted from the results of a series of catechin dilutions (7.81, 15.62, 31.25, 62.50, 125, and 250 μg/ml). e results were expressed as milligrams of catechin equivalent per gram of extract (mg CE/g of extract).

Inhibition of Bovine Serum Albumin (BSA)
Denaturation. Inhibition of protein denaturation was evaluated using the method of Rahman et al. [16]. Nine hundred microliters (900 μl) of 1% bovine serum albumin (BSA) was added to 100 μl of the extracts at varying concentrations (62.5, 125, 250, 500, and 1000 μg/ml). is was then allowed to stand at room temperature for 10 mins, followed by heating at 70°C for 15 mins. e reaction mixture was then allowed to cool at room temperature, and the absorbance was recorded at 660 nm. Diclofenac sodium was used as a positive control. e percentage inhibition of protein denaturation was calculated using the formula below: where test � absorbance of sample (plant extract or diclofenac sodium) and blank � absorbance of enzyme + substrate. e IC 50 (the concentration causing 50% of inhibition) was obtained from the linear regression curve.

Proteinase Inhibitory Action.
e test was conducted in accordance with the method described by Gulnaz [17] with some modifications. e reaction mixture (2 ml) contained 60 μg of trypsin, 1000 μl of 20 mM Tris HCl buffer (pH 7.4), and 1 ml extract at different concentrations (62.5, 125, 250, 500, and 1000 μg/ml). e mixture was incubated at 37°C for 5 mins and then 1 ml of 0.8% (w/v) casein was added. e mixture was incubated for an additional 20 mins at 37°C. Hence, 2 ml of 70% perchloric acid was added to stop the reaction. A cloudy suspension was centrifuged at 3000 rpm (revolutions per min) for 10 mins, and the absorbance of the supernatant (containing short chains of amino acids, dipeptides, and polypeptides) was read at 210 nm against Tris HCl buffer as blank.
e percentage inhibition of proteinase activity was calculated as earlier mentioned above. e values of the IC 50 were graphically obtained from the linear regression.

Pancreatic Lipase Inhibition Methods.
e method described by Kim et al. [18] was used in this assay. Eighty microliters (80 μl) of each extract at different concentrations (3.125, 6.25, 12.5, 25, 50, 100, and 200 μg/ml) was mixed with 20 μl of porcine pancreatic lipase (4 mg/ml) and 90 μl of phosphate buffer. e mixture was then incubated at 37°C for 37 mins. e reaction was started by the addition of 10 μl of p-nitrophenyl butyrate substrate (10 mM p-NPB) in dimethylformamide. After 30 mins of incubation at 37°C, the lipase inhibitory activity was determined by measuring the hydrolysis of p-NPB to p-nitrophenol at 405 nm using an ELISA microplate reader (BK-EL10 C). Orlistat was used as the standard. e percentage of inhibition was calculated using the following formula: where test � absorbance of sample (plant extract or orlistat) and blank � absorbance of enzyme + substrate. Antilipase activity is given as IC 50 values (the concentrations that inhibited the hydrolysis of p-NPB to p-nitrophenol by 50%).

Cholesterol Esterase Inhibition Method.
e inhibition of pancreatic cholesterol esterase was carried out according to the method described by Adisakwattana et al. [19]. Briefly, 50 μl of the extracts at different concentrations (3.12, 6.25, 12.5, 25, 50, 100, and 200 μg/ml) was added to 50 μl of 5.16 mM taurocholic acid and 50 μl of an aqueous solution of cholesterol esterase and incubated for 10 mins at 25°C. en, 50 μl of p-nitrophenyl butyrate substrate (0.2 mM) was added to the mixture and incubated for 5 mins at 25°C. Cholesterol esterase inhibitory activity was determined by measuring the hydrolysis of p-NPB to p-nitrophenol at 405 nm using an ELISA microplate reader (BK-EL10 C). Orlistat was used as the standard. e percentage of inhibition was calculated using the following formula: where test � absorbance of sample (plant extract or orlistat) and blank � absorbance of enzyme + substrate. Anticholesterol esterase activity is given as IC 50 values (the concentrations that inhibited 50% of the hydrolysis of pNPB to p-nitrophenol).

Alpha-Amylase Inhibition Assay.
e method earlier described by Ademiluyi and Oboh [20] was used in this assay. Fifty microliters (50 μl) of extract at different concentrations (3.12, 6.25, 12.5, 25, 50, 100, and 200 μg/ml) was mixed with 10 μl of α-amylase solution (500 μg/ml) and incubated for 10 mins at 37°C. en, 40 μl of starch solution (0.25%) was added to the mixture and incubated for 30 mins at 37°C. en, 20 μl of 1M HCl was added to stop the enzyme reaction, and 80 μl of Lugol was added to reveal the presence of starch. e intensity of the blue color was proportional to the amount of starch remaining. Acarbose was used as the positive control. e absorbance was read at 620 nm using an ELISA microplate reader (BK-EL10 C). e percentage of inhibition was calculated using the following formula: where test � absorbance of sample (plant extract or acarbose) and blank � absorbance of enzyme + substrate.

Pancreatic Alpha-Glucosidase Inhibitory
Activity. e effect of the plant extracts on alpha-glucosidase activity was determined according to the chromogenic method described by Mumtaz et al. [21] with slight modifications. Eighty microliters (80 μl) of extract or acarbose (standard) at different concentrations (3.12, 6.25, 12.5, 25, 50, 100, and 200 μg/ml) was added to 10 μl of alpha-glucosidase 1 U/ml and incubated for 10 mins at 37°C. en, 10 μl of p-nitrophenyl-α-D-glucopyranoside was also added to the mixture and incubated at 37°C for 30 mins. Finally, 100 μl of 0.2 M sodium carbonate was added to stop the reaction, and the absorbance was read at 405 nm using an ELISA microplate reader (BK-EL10 C). Percentage inhibition was calculated using the following formula: where test � absorbance of sample (plant extract or acarbose) and blank � absorbance of enzyme + substrate.

Statistical Analysis.
All the results (in triplicate) were expressed as mean ± standard deviation (SD) using Microsoft Excel 2016. Statistical analysis for group comparison was carried out by using analysis of variance (ANOVA). Significant differences between groups were determined by Dunnett's multiple comparison test at p < 0.001. e statistical software used was GraphPad prism 5.

Preliminary Phytochemical
Screening. e phytochemical screening of the extracts of P. densinervia revealed the presence of secondary metabolites such as alkaloids, phenolic compounds, flavonoids, coumarins, steroids saponins, terpenoids, and tannins, presented in Table 1. e polyphenols, flavonoids, terpenoids, and steroids were more abundant in the P. densinervia leaf extract than the bark extract, while the composition of alkaloids, coumarins, saponins, and tannins was similar in both the extracts.
e percentage of DPPH radical scavenging activity of the extracts was dose-dependent ( Figure 2). e curve observed for both the extract and the standard were sigmoidal turning toward saturation at optimal concentration. At 250 μg/ml concentration, all extracts showed inhibition percentages greater than 80%. e IC 50 of DPPH radical scavenging activity is presented in Table 2. e leaf extract showed better DPPH radical scavenging activity with a significantly low IC 50 value (59.09 ± 5.97 μg/ml, p < 0.001) compared to ascorbic acid (IC 50 � 71.78 ± 6.37 μg/ml) and bark extract (IC 50 � 115.40 ± 1.21 μg/ml). e lower the IC 50 is, the better the radical scavenging activity. Figure 3 presents the ABTS free radical scavenging activity of the plant extracts. At a concentration of 500 μg/ml, all extracts exhibited a percentage of radical scavenging activity greater than 80%. However, catechin had the highest inhibition percentage compared to both the plant extracts. e IC 50 of the extract scavenging the ABTS radical activity is presented in Table 2. It was observed that catechin exhibited the lowest IC 50 indicating the highest antioxidant activity (IC 50 � 33.48 ± 2.02 μg/ ml) followed by the leaf extract (262.4 ± 4.46 μg/ml) and then the bark extract (354.2 ± 1.97 μg/ml).

Ferric Reducing Antioxidant Potential (FRAP).
Ferric reducing antioxidant power of the extracts is presented in Table 2. e leaf extract exhibited a significantly higher FRAP activity (341.73 ± 2.17 mg CE/g of extract, p < 0.001) than the bark extract (150.30 ± 0.32 mg CE/g of extract).

Determination of Polyphenol and Flavonoid Content.
e polyphenol and flavonoid content in the dried bark and dried leaves was determined in milligrams equivalent  Advances in Pharmacological and Pharmaceutical Sciences catechin per gram of P. densinervia extracts (Table 3). e leaf extract significantly showed a higher polyphenol content (270.05 ± 7.53 mg CE/gg of extract, p < 0.001) compared to the bark extract (138.89 ± 0.91 mg CE/g of extract). In addition, it was observed that the flavonoid content of the leaf extract (23.43 ± 0.03 mg CE/g of extract) was significantly (p < 0.01) higher than that of the bark extract (20.06 ± 0.03 mg CE/g of extract).

Protein Denaturation Inhibition Test.
e data obtained for the anti-inflammatory property of P. densinervia revealed that protein denaturation inhibition was dose-dependent ( Figure 4). e highest inhibition percentage of protein denaturation was obtained by sodium diclofenac, the standard drug. Table 4 presents the IC 50 values in (μg/ml) of the extracts and sodium diclofenac against protein denaturation. e leaf extract showed a significant (p < 0.001) lower IC 50 with a value of 257.0 ± 7.51 μg/ml compared to the bark extract with the IC 50 value as 316.1 ± 6.02 μg/ml. Furthermore, IC 50 of the leaf extract was significantly (p < 0.001) higher than the sodium diclofenac IC 50, the standard drug (207.6 ± 3.94 μg/ml).

Antiproteinase Activity.
e antiproteinase activity of the extracts and the reference standard (sodium diclofenac) are presented in Figure 5. e antiproteinase action of both P. densinervia extracts and sodium diclofenac were concentration-dependent. e inhibition percentage of the proteinase activity of the leaf extract was higher than that of the bark extract, which was in turn higher than that of sodium diclofenac. Both extracts of P. densinervia showed good antiproteinase activity compared to sodium diclofenac. e IC 50 of the leaf extract (74.37 ± 1.10 μg/ml) was significantly (p < 0.001) lower than the bark extract (IC 50 � 177.6 ± 0.50 μg/ml), which was also significantly lower than the sodium diclofenac (IC 50 � 322.8 ± 2.75 μg/ ml) ( Table 4). is indicates the effectiveness of the extract in inhibiting protein digestive enzymes.     Figure 6 presents the lipase inhibitory activity of extracts and the standard. Data presented showed that both the extract and reference standard (orlistat) inhibited the lipase activity in a concentration-dependent manner. e inhibition percentage of lipase by P. densinervia hydro-ethanolic leaf and bark extracts (61.49 ± 0.36% and 60.32 ± 0.54 respectively) were lower than that of the standard orlistat (97.83 ± 0.34%) at a concentration of 200 μg/ml. e best inhibiting activity of pancreatic lipase was found with orlistat, the reference standard, where the IC 50 value was 37.11 ± 4.39 μg/ml, which was significantly lower (p < 0.001) compared to leaf and bark extracts with an IC 50 , respectively ,of 50.57 ± 2.89 μg/ml and 62.88 ± 1.74 μg/ml, respectively (Table 5).

Pancreatic Cholesterol Esterase
Inhibition. e effect of both extracts and reference drug (orlistat) on cholesterol esterase activity is presented in Figure 7. It is observed that all the three tested samples had a significant pancreatic cholesterol esterase inhibition activity, which was concentration-dependent. e bark extract of P. densinervia had the lowest inhibitory effect on cholesterol esterase activity. At the smallest concentration, orlistat had a better inhibition percentage right to the log concentration of 1.5 μg/ml, where there was an intercept with the P. densinervia leaf extract. At log concentration above 1.5 μg/ml, the leaf extract of P. densinervia presented a higher percentage of inhibition activity compared to orlistat. e calculated IC 50 for P. densinervia extracts and orlistat are presented in Table 5.

Inhibition of Pancreatic α-Amylase.
e inhibitory activity of P. densinervia hydro-ethanolic extracts and acarbose on pancreatic α-amylase activity showed a concentration-response effect (Figure 8). All the three tested samples presented a sigmoidal curve reaching saturation at the log concentration of 1.75 μg/ml. e results of the leaf extract showed the highest percentage inhibition of pancreatic α-amylase activity compared to bark extract and acarbose. Considering the IC 50 values, the leaf extract had a value (IC 50 � 6.06 ± 4.05 μg/ml), which was significantly lower (p < 0.001) than that of the bark extract (IC 50 � 19.69 ± 6.27 μg/ml) and the reference drug acarbose (IC 50 � 20.01 ± 2.84 μg/ml). is makes the leaf extract more Data are expressed as mean ± SD; n � 3; significantly different at * * * p < 0.001 when compared to sodium diclofenac. † p < 0.01 compared to bark extract. e bark extract showed an inhibitory activity similar to acarbose (Table 5).

Inhibition of Pancreatic α-Glucosidase.
e results of the percentage inhibition of α-glucosidase activity of P. densinervia hydroethanolic extracts and acarbose also showed a concentration-response effect (Figure 9). At a log concentration of 0.5 to 1.75 μg/ml, the reference drug acarbose showed a higher percentage inhibition of α-glucosidase than P. densinervia hydroethanolic extracts. At the log concentration of 2 to 2.5 μg/ml, the leaf extract had a higher percentage inhibition effect on α-glucosidase than acarbose. When calculated, the IC 50 of acarbose was significantly lower (4.11 ± 3.47 μg/ml, p < 0.001) compared to the leaf extract (IC 50 � 24.41 ± 2.84 μg/ml) and bark extract (IC 50 � 38.81 ± 2.46 μg/ml) ( Table 5). is makes acarbose a better inhibitor of α-glucosidase than the plant extracts. However, the leaf extract has shown greater inhibitory activity than the bark extract. Data are expressed as mean ± SD, n � 3; significantly different at * * * p < 0.001 when compared to standards (orlistat) in lipase and cholesterol esterase inhibition tests; acarbose in α-amylase and α-glucosidase inhibition test). † p < 0.001 compared to bark extract.

Discussion
Obesity is defined as a chronic state of oxidative stress and inflammation, even in the absence of other risk factors, indicating that these metabolic mechanisms (oxidative stress and inflammation) are present and could contribute to the development of the metabolic syndrome [22]. Metabolic syndrome is responsible for the development of illnesses such as type 2 diabetes, cardiovascular disease, arthritis, hypertension, cardiac arrest, and certain cancers [23,24].
Phytochemical screening (Table 1) of P. densinervia extracts revealed the presence of secondary metabolites such as alkaloids, phenolic compounds, flavonoids, coumarins, steroids saponins, terpenoids, and tannins. Alkaloids have earlier been associated with reduction in the expression of adipocyte marker genes, which enhances binding proteins and proliferator-activated receptor, thereby inhibiting adipogenesis, leading to antiobesity activities [25,26]. On the other hand, flavonoids and phenols have been reported to exert an antioxidant activity, which may be important in modulating obesity-related oxidative stress in the body [25,26]. Coumarins possess antiobesity activities mainly by inhibiting lipogenesis in adipocytes [27]. Steroids have been known to contribute to cholesterol and low-density lipoprotein reduction in serum, and compete with cholesterol for micelle formation in the intestinal lumen [26,28]. Saponins and flavonoids are known to decrease the level of triglycerides and total cholesterol by the formation of large micelles excreted in bile. Also, they decrease the absorption of cholesterol in the intestines and serum levels of lowdensity lipoprotein cholesterol, playing a role in weight loss [26,29]. Terpenoids are involved in hypolipidemic activity by inhibiting pancreatic lipase [30]. Tannins have antioxidant and antilipase activities [31]. Both leaf and bark extracts of P. densinervia contain these bioactive components and may be responsible in one way or the other for the biological activities of the plant. e leaf extract of P. densinervia presented denser coloration in phytochemistry studies indicating the abundance of phytochemical constituents responsible for the antiobesity activity [32].
In the DPPH and ABTS radical scavenging activities, the hydro-ethanolic leaf extract of P. densinervia showed a higher free-radical scavenging activity compared to the hydro-ethanolic bark extract of P. densinervia. is is correlated with the high total polyphenols and flavonoids content, which are higher than that of the bark extract. In the ABTS test, it appears that catechin exhibited the highest ABTS scavenging activity than the leaf extract. However, for the DPPH and ABTS tests at the concentration of 250 μg/ml, both leaf and bark extracts exhibited an inhibition percentage greater than 80%. It has been reported that the production of free radicals responsible for oxidative stress is equally increased in adipose tissues and liver of mice fed with a high-fat diet [33]. erefore, the free radical scavenging capacities exhibited in this study by the leaf and bark extract might have occurred through the transfer of electrons and hydrogen atoms in the DPPH test and through electron donation in the ABTS test, which is important for the prevention of oxidative stress development.
Phytochemical compounds often possess ferric reducing capacity as electron donors, thus reducing oxidized intermediates such as those of lipid peroxidation processes [34]. In this study, the hydro-ethanolic leaf extract of P. densinervia exhibited a higher ferric reducing antioxidant power than the hydro-ethanolic bark extract. e antioxidant potential of the leaf extract can play a role in the prevention of protein denaturation, lipid peroxidation, and the disruption of membrane fluidity implicated in oxidative stress [34]. e marked electron donation ability of the leaf extract could be attributed to its polyphenolic and flavonoid content, which can transfer electrons to neutralize free radicals, chelate metal catalysts, and activate antioxidant enzymes [34].
Systemic inflammation-associated obesity is characterized by increased circulating concentrations of proinflammatory cytokines and chemokines, and activation of pathways that regulate inflammation. A protein denaturation assay was used in this study as an evidence for the membrane-stabilizing properties. Proteins are denatured when they lose their secondary and tertiary structures through the application of external stress or compounds such as heat, strong acids, or bases. e denaturation of tissue proteins leads to the production of autoantigens [35,36]. erefore, any agent that can prevent protein denaturation is worth considering for anti-inflammatory drug development. Most nonsteroidal anti-inflammatory drugs (NSAIDs) are known to possess the intrinsic ability to stabilize or prevent heat-treated albumin denaturation at physiological pH 6.2-6.5 [35,37]. Also, it has been reported that the administration of NSAIDs to overweight patients may improve the loss in their body weight [38]. In the present investigation, the leaf extract exhibited a higher protein denaturation inhibition than the bark extract. e activity of the leaf extract was lower than the sodium diclofenac, which implied that this extract could be used as an alternative to synthetic NSAIDs.
Leukocytes, in their lysosomal granules, carry many serine proteinases [39,40]. us, during inflammation, as part of their defensive roles, leukocytes release their lysosomal enzymes, including proteinases, causing further tissue damage and subsequent inflammation [39,41]. Damage to cell membranes will further make the cell more susceptible to secondary damage by free radical-induced lipid peroxidation [39,42], which may lead to atherosclerosis. In this study, the hydro-ethanolic leaf extract showed higher antiproteinase activity than the sodium diclofenac, which was higher than the hydro-ethanolic bark extract. It might be suggested that P. densinervia extracts and especially the leaf extract might inhibit the release of the lysosomal constituents of leukocytes at the site of inflammation. e development of obesity is closely related to the metabolism of body fat. Exogenous fat cannot be directly used by the human body without being hydrolyzed for absorption [43]. Pancreatic lipase hydrolyzes triacylglycerol into free fatty acids in the intestine for absorption [43]. From there, the monoglycerides and free fatty acids are subsequently moved to enterocytes, cells lining the intestines, and then absorbed [43,44]. In fact, the inhibition of pancreatic Advances in Pharmacological and Pharmaceutical Sciences lipase activity is expected to limit dietary fat absorption, resulting in delayed triglyceride digestion. e hydroethanolic leaf extract showed a significantly higher activity than the bark extract. e hydroxyl groups of phenolic compounds present in extracts are reported to form hydrophobic interactions with amino acid residues of pancreatic lipase, which lead to inhibition [45]. Dietary cholesterol consists of both free and esterified cholesterol. Esterified cholesterols are hydrolyzed by pancreatic cholesterol esterase to release free cholesterol in the small intestines [46]. Moreover, it plays an important role in regulating the incorporation of cholesterol into mixed micelles [47] and its transportation into the blood plasma. erefore, the inhibition of cholesterol esterase is crucial to restrict and delay the absorption of dietary cholesterol in the small intestine. Lowering of cholesterol absorption by inhibiting the cholesterol esterase is a good strategy for the management of hyperlipidemia and obesity [48,49]. e hydro-ethanolic leaf extract of P. densinervia showed a significantly higher inhibition than the reference orlistat and bark extract P. densinervia. e mechanism of cholesterol esterase inhibition may be due to the interaction of phenolic compounds contained in extracts with the potent cholesterol esterase inhibitory sites, especially the interaction with the catalytic triad and oxyanion hole residues [50].
Alpha-amylase and α-glucosidase are two enzymes involved in the hydrolysis of polysaccharides and disaccharides into simple sugars [51]. Inhibition of these enzymes impairs the digestion of carbohydrates and limits their absorption into the bloodstream [51]. is inhibition could be a way of fighting obesity due to hepatic lipogenesis. Inhibition of α-glycosidase prolongs gastric emptying, leading to satiety and weight loss, effects of which may be useful in the treatment of obesity [52]. P. densinervia leaf extract showed a significantly high inhibition of α-amylase than the reference acarbose and the bark extract. In the α-glycosidase test, acarbose showed significant high activity. e leaf extract exhibited a higher activity than the bark extract. ese activities may be due to the presence of different bioactive compounds contained in the extracts.

Conclusion
is study examines the in vitro antioxidant, anti-inflammatory, and digestive enzymes inhibition activities of hydroethanolic leaf and bark extracts of Psychotria densinervia. e results showed that the hydro-ethanolic leaf and bark extracts of Psychotria densinervia contained bioactive compounds such as alkaloids, phenolic compounds, flavonoids, coumarins, steroids saponins, terpenoids, and tannins. e hydroethanolic leaf extract exhibited a higher total phenolic and flavonoids content than the bark extract. e hydro-ethanolic leaf and bark extracts showed good antioxidant, anti-inflammatory activities, as well as good enzyme digestion inhibition activities. e leaf extract was more effective than the bark extract in all activities. erefore, Psychotria densinervia hydro-ethanolic leaf extract could be used for the management of obesity. However, several mechanisms of action of the plant need to be elucidated.

Data Availability
All data used in this study are presented as results.

Conflicts of Interest
e authors declare that they have no conflicts of interest.